期刊文献+

恩利治疗强直性脊柱炎病人的观察及护理 被引量:2

Observation and nursing care of ankylosing spondylitis patients treated with Enli
下载PDF
导出
摘要 [目的]探讨恩利治疗强直性脊柱炎病人的护理。[方法]为32例应用恩利治疗的强直性脊柱炎病人慎重选择及合理更换皮下注射部位,严密观察病情变化,发现不良反应及时给予恰当处理,加强健康指导工作,保证治疗过程的顺利进行。[结果]通过精心护理,病人能以积极的心态接受治疗,其红细胞沉降率、C反应蛋白、Bath疾病活动指数、功能指数治疗前后比较差异有统计学意义(P<0.05)。[结论]对应用恩利治疗的强直性脊柱炎病人加强观察和护理有助于提高病人治疗效果。
作者 阎敏 张素文
出处 《护理研究(中旬版)》 2011年第2期424-425,共2页 Chinese Nursing Researsh
  • 相关文献

参考文献8

  • 1Garrett S,Jenkinson T,Kennedy LF,et al.A new approach todefining disease status in ankylosing spondylitis:The bath ankylosing spondylitis disease activity index[J].Rheumatol,1994,21:2286-2291.
  • 2Calin A,Garrett S,Whitelock H,et al.A new approach to defining functional ability in ankylosing spondylitis:The development of the bath ankylosing spondylitis function index[J].Rheumatol,1994,21:2281-2285.
  • 3Berg PA.Risks and side effect reaction during therapy with TNF-alpha blockers:An immunologic analysis[J].Dtsch Med Wochenschr,2004,129(30):1631-1634.
  • 4张建华,李亚琴,杨晓丽.48例强直性脊柱炎病人的护理干预[J].护理研究(上旬版),2010,24(6):1468-1469. 被引量:8
  • 5Brophy S,Mackay K,Al-Saidi A,et al.The natural history of ankylosing spondylitis as defined by radiological progression[J].J Rheumatol,2002,29:1236-1243.
  • 6马丽,杨岫岩.重视强直性脊柱炎的髋关节病变[J].中华风湿病学杂志,2008,12(5):289-290. 被引量:11
  • 7Kavanaugh A,Tutuncu Z,Catalan-Sanchez T.Update on antitumornecrosis factor therapy in the spondyloarthropathies including psoriatic arthritis[J].Curr Opin Rheumatol,2006,18:347-353.
  • 8McCormack PL,Wellington K.Etanercept in ankylosing spondylitis[J].2004,18(3):199-205.

二级参考文献12

  • 1赵福涛,管剑龙,韩星海.甲氨蝶呤治疗强直性脊柱炎髋关节病变的临床研究[J].中华风湿病学杂志,2007,11(4):213-216. 被引量:11
  • 2Brophy S, Mackay K, Al-Saidi A, et al. The natural history of ankylosing spondylitis as defined by radiological progression. J Rheumatol, 2002, 29: 1236-1243.
  • 3Robertson LP, Davis MJ. A longitudinal study of disease activity and functional status in a hospital cohort of patients with ankylosing spondylitis. Rheumatology (Oxford), 2004, 43: 1565- 1568.
  • 4Brophy S, Calin A. Ankylosing spondylitis: interaction between genes, joints, age at onset,and disease expression. J Rheumatol, 2001, 28: 2283-2288.
  • 5Georg Schett. Joint remodeling in inflammatory disease. Ann Rheum Dis, 2007, 66(Suppl 3): 42-44.
  • 6Zochling J, Van HD, Burgos VR, et al. ASAS/EU LAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis, 2006, 65: 442-452.
  • 7Vander Cruyssen B, Ribbens C, Boonen A, et al. The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice. Ann Rheum Dis, 2007, 66: 1072-1077.
  • 8Pham T, Landewe R, van der Linden S, et al. An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis. Ann Rheum Dis, 2006, 65: 1620-1625.
  • 9Gadsby K, Deighton C. Characteristics and treatment responses of patients satisfying the BSR guidelines for anti-TNF in ankylosing spondylitis. Rheumatology (Oxford), 2007, 46: 439-441.
  • 10Baraliakos X, Listing J, Brandt J, et al. Radiographic progression in patients with ankylosing spondylitis after 4 years of treatment with the anti-TNF-alpha antibody infliximab.Rheumatology (Oxford), 2007, 46: 1450-1453.

共引文献17

同被引文献21

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部